NCT05088772View on ClinicalTrials.gov

Pulmonary Function After Hyperbaric Oxygen Therapy

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2021

Study Completion Date

October 31, 2022

Conditions
Oxygen Toxicity
Interventions
DEVICE

Hyperbaric Oxygen Therapy

"Hyperbaric Oxygen Therapy performed at 100% oxygen at 2.0-2.4 ATA, with 1-3 air breaks, typically at 5 sessions per week, with limited variation depending on the treatment indication and patient/clinician preference."

Trial Locations (1)

M5G 2C4

Hyperbaric Medicine Unit, Toronto

All Listed Sponsors
lead

University of Toronto

OTHER

NCT05088772 - Pulmonary Function After Hyperbaric Oxygen Therapy | Biotech Hunter | Biotech Hunter